Tapewire

Nasdaq · USD

CADL

Candel Therapeutics, Inc.

Export transactions ↓
Tapewire entity
4969
SEC CIK
0001841387
Parsed reports
200

Last 12 months

Inside the activity.

1 purchase rows · 5 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202610
Mar 202600
Apr 202600
May 202600
Jun 202602
Jul 202600
Aug 202601
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 13, 2022 Filed Oct 17, 2022 20:45 UTC
Nguyen DiemDirector
GrantStock Option (Right to Buy) · Derivative 14,240 $0.00 Strike: $2.81 $0.00
Disclosure

SEC source: 0001209191-22-053830 · doc4.xml · derivative · entry 1

Nguyen Diem · CIK 0001814338 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,240

Underlying: Common Stock · 14,240 shares

Expires 2032-10-13

F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) October 13, 2023 or (ii) the date of the next Annual Meeting of Stockholders of the Company; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors of the Company or otherwise ceases to serve as a Director, unless the Board determines that the circumstances warrant continuation of vesting.

Read SEC document
October 13, 2022 Filed Oct 17, 2022 20:42 UTC GrantStock Option (Right to Buy) · Derivative 14,240 $0.00 Strike: $2.81 $0.00
Disclosure

SEC source: 0001209191-22-053831 · doc4.xml · derivative · entry 1

Martell Christopher · CIK 0001873465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,240

Underlying: Common Stock · 14,240 shares

Expires 2032-10-13

F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) October 13, 2023 or (ii) the date of the next Annual Meeting of Stockholders of the Company; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors of the Company or otherwise ceases to serve as a Director, unless the Board determines that the circumstances warrant continuation of vesting.

Read SEC document
October 13, 2022 Filed Oct 17, 2022 20:36 UTC GrantStock Option (Right to Buy) · Derivative 14,240 $0.00 Strike: $2.81 $0.00
Disclosure

SEC source: 0001209191-22-053829 · doc4.xml · derivative · entry 1

Benz Edward J. JR · CIK 0001691160 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,240

Underlying: Common Stock · 14,240 shares

Expires 2032-10-13

F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) October 13, 2023 or (ii) the date of the next Annual Meeting of Stockholders of the Company; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors of the Company or otherwise ceases to serve as a Director, unless the Board determines that the circumstances warrant continuation of vesting.

Read SEC document
October 13, 2022 Filed Oct 17, 2022 20:36 UTC GrantStock Option (Right to Buy) · Derivative 14,240 $0.00 Strike: $2.81 $0.00
Disclosure

SEC source: 0001209191-22-053828 · doc4.xml · derivative · entry 1

Manning Paul B · CIK 0001494695 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,240

Underlying: Common Stock · 14,240 shares

Expires 2032-10-13

F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) October 13, 2023 or (ii) the date of the next Annual Meeting of Stockholders of the Company; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors of the Company or otherwise ceases to serve as a Director, unless the Board determines that the circumstances warrant continuation of vesting.

Read SEC document
October 13, 2022 Filed Oct 17, 2022 20:45 UTC GrantStock Option (Right to Buy) · Derivative 14,240 $0.00 Strike: $2.81 $0.00
Disclosure

SEC source: 0001209191-22-053833 · doc4.xml · derivative · entry 1

Aguilar-Cordova Estuardo · CIK 0001873919 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,240

Underlying: Common Stock · 14,240 shares

Expires 2032-10-13

F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) October 13, 2023 or (ii) the date of the next Annual Meeting of Stockholders of the Company; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors of the Company or otherwise ceases to serve as a Director, unless the Board determines that the circumstances warrant continuation of vesting.

Read SEC document
September 21, 2022 Filed Sep 23, 2022 16:15 UTC
Amello JasonChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 230,000 $0.00 Strike: $3.21 $0.00
Disclosure

SEC source: 0001209191-22-051131 · doc4.xml · derivative · entry 1

Amello Jason · CIK 0001451805 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 230,000

Underlying: Common Stock · 230,000 shares

Expires 2032-09-21

F1 · derivative.exercise_date: 25% of the shares underlying this option shall vest and become exercisable on September 21, 2023, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
September 12, 2022 Filed Sep 14, 2022 17:05 UTC
Nichols William GarrettChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 200,000 $0.00 Strike: $3.75 $0.00
Disclosure

SEC source: 0000899243-22-031059 · doc4.xml · derivative · entry 1

Nichols William Garrett · CIK 0001618364 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2032-09-12

F1 · derivative.exercise_date: The first 100,000 shares underlying this option shall vest as follows: 25% shall vest and become exercisable on September 12, 2023, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. The remaining 100,000 shares underlying this option shall vest as follows: 25% shall vest and become exercisable on the first anniversary of the date in which the Reporting Person converts to a full-time employee, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
August 08, 2022 Filed Aug 10, 2022 12:05 UTC
Gaeta ReneeDirector
GrantStock Option (Right to Buy) · Derivative 28,480 $0.00 Strike: $3.38 $0.00
Disclosure

SEC source: 0000899243-22-028203 · doc4.xml · derivative · entry 1

Gaeta Renee · CIK 0001742428 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,480

Underlying: Common Stock · 28,480 shares

Expires 2032-08-08

F1 · derivative.exercise_date: 33% of the shares underlying this option shall vest and become exercisable on August 8, 2023, with the remainder vesting in two (2) equal annual installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
August 08, 2022 Filed Aug 10, 2022 12:05 UTC GrantStock Option (Right to Buy) · Derivative 28,480 $0.00 Strike: $3.38 $0.00
Disclosure

SEC source: 0000899243-22-028201 · doc4.xml · derivative · entry 1

PAPA JOSEPH C · CIK 0001242215 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,480

Underlying: Common Stock · 28,480 shares

Expires 2032-08-08

F1 · derivative.exercise_date: 33% of the shares underlying this option shall vest and become exercisable on August 8, 2023, with the remainder vesting in two (2) equal annual installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
August 08, 2022 Filed Aug 10, 2022 12:05 UTC GrantStock Option (Right to Buy) · Derivative 28,480 $0.00 Strike: $3.38 $0.00
Disclosure

SEC source: 0000899243-22-028202 · doc4.xml · derivative · entry 1

Nabel Gary J. · CIK 0001867450 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,480

Underlying: Common Stock · 28,480 shares

Expires 2032-08-08

F1 · derivative.exercise_date: 33% of the shares underlying this option shall vest and become exercisable on August 8, 2023, with the remainder vesting in two (2) equal annual installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
May 06, 2022 Filed May 10, 2022 22:07 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 76,717 $0.00 Strike: $1.46 $0.00
Disclosure

SEC source: 0000899243-22-017477 · doc4.xml · derivative · entry 6

Aguilar Laura K. · CIK 0001873915 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 76,717 shares

Expires 2028-11-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · shares: Includes options that were previously subject to performance vesting criteria. Upon the Reporting Person's termination as an officer of the Issuer, the vesting conditions were waived, and the shares underlying this option became fully vested and exercisable.

F4 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof.

Read SEC document
May 06, 2022 Filed May 10, 2022 22:07 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 76,717 $0.00 Strike: $1.46 $0.00
Disclosure

SEC source: 0000899243-22-017477 · doc4.xml · derivative · entry 5

Aguilar Laura K. · CIK 0001873915 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 76,717 shares

Expires 2028-11-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof.

Read SEC document
May 06, 2022 Filed May 10, 2022 22:07 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 17,901 $0.00 Strike: $1.46 $0.00
Disclosure

SEC source: 0000899243-22-017477 · doc4.xml · derivative · entry 4

Aguilar Laura K. · CIK 0001873915 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 17,901 shares

Expires 2028-08-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof.

Read SEC document
May 06, 2022 Filed May 10, 2022 22:07 UTC Tax withholdingCommon Stock 68,534 $3.65 $250,149.10
Disclosure

SEC source: 0000899243-22-017477 · doc4.xml · nonDerivative · entry 2

Aguilar Laura K. · CIK 0001873915 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,033,840

F2 · kind: Represents a net exercise of outstanding stock options. These shares were resold to the Issuer as payment of the exercise price, based on the closing price of the Issuer's common stock on May 5, 2022 of $3.65 per share.

F1 · balance_after: Includes 32,399 shares of common stock held jointly with spouse.

Read SEC document
May 06, 2022 Filed May 10, 2022 22:07 UTC Exercise / conversionCommon Stock 171,335 $1.46 $250,149.10
Disclosure

SEC source: 0000899243-22-017477 · doc4.xml · nonDerivative · entry 1

Aguilar Laura K. · CIK 0001873915 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,102,374

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 32,399 shares of common stock held jointly with spouse.

Read SEC document
May 06, 2022 Filed May 10, 2022 22:04 UTC
Aguilar-Cordova EstuardoDirector · 10% owner
Exercise / conversionStock Option (Right to Buy) · Derivative 46,261 $0.00 Strike: $1.46 $0.00
Disclosure

SEC source: 0000899243-22-017474 · doc4.xml · derivative · entry 6

Aguilar-Cordova Estuardo · CIK 0001873919 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,456

Underlying: Common Stock · 46,261 shares

Expires 2023-11-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · shares: Includes options that were previously subject to performance vesting criteria. Upon the Reporting Person's termination as an officer of the Issuer, the vesting conditions were waived, and the shares underlying this option became fully vested and exercisable.

F4 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof.

Read SEC document
May 06, 2022 Filed May 10, 2022 22:04 UTC
Aguilar-Cordova EstuardoDirector · 10% owner
Exercise / conversionStock Option (Right to Buy) · Derivative 76,717 $0.00 Strike: $1.46 $0.00
Disclosure

SEC source: 0000899243-22-017474 · doc4.xml · derivative · entry 5

Aguilar-Cordova Estuardo · CIK 0001873919 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 76,717 shares

Expires 2023-11-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof.

Read SEC document
May 06, 2022 Filed May 10, 2022 22:04 UTC
Aguilar-Cordova EstuardoDirector · 10% owner
Exercise / conversionStock Option (Right to Buy) · Derivative 12,205 $0.00 Strike: $1.46 $0.00
Disclosure

SEC source: 0000899243-22-017474 · doc4.xml · derivative · entry 4

Aguilar-Cordova Estuardo · CIK 0001873919 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,205 shares

Expires 2028-08-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof.

Read SEC document
May 06, 2022 Filed May 10, 2022 22:04 UTC
Aguilar-Cordova EstuardoDirector · 10% owner
Tax withholdingCommon Stock 54,074 $3.65 $197,370.10
Disclosure

SEC source: 0000899243-22-017474 · doc4.xml · nonDerivative · entry 2

Aguilar-Cordova Estuardo · CIK 0001873919 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,097,032

F2 · kind: Represents a net exercise of outstanding stock options. These shares were resold to the Issuer as payment of the exercise price, based on the closing price of the Issuer's common stock on May 5, 2022 of $3.65 per share.

F1 · balance_after: Includes 32,399 shares of common stock held jointly with spouse.

Read SEC document
May 06, 2022 Filed May 10, 2022 22:04 UTC
Aguilar-Cordova EstuardoDirector · 10% owner
Exercise / conversionCommon Stock 135,183 $1.46 $197,367.18
Disclosure

SEC source: 0000899243-22-017474 · doc4.xml · nonDerivative · entry 1

Aguilar-Cordova Estuardo · CIK 0001873919 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,151,106

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 32,399 shares of common stock held jointly with spouse.

Read SEC document
April 14, 2022 Filed Apr 15, 2022 21:05 UTC
Tyagarajan SeshuSee Remarks
GrantStock Option (Right to Buy) · Derivative 120,000 $0.00 Strike: $5.19 $0.00
Disclosure

SEC source: 0000899243-22-014892 · doc4.xml · derivative · entry 1

Tyagarajan Seshu · CIK 0001923794 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Stock · 120,000 shares

Expires 2032-04-14

F1 · derivative.exercise_date: 25% of the shares underlying this option shall vest and become exercisable on April 14, 2023, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
April 11, 2022 Filed Apr 12, 2022 17:15 UTC
Stewart Susan B.Chief Regulatory Officer
GrantStock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $5.12 $0.00
Disclosure

SEC source: 0000899243-22-014591 · doc4.xml · derivative · entry 1

Stewart Susan B. · CIK 0001618249 · Chief Regulatory Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2032-04-11

F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments, with the first installment vesting on May 11, 2022, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
February 28, 2022 Filed Mar 1, 2022 23:34 UTC
Barone FrancescaChief Scientific Officer
GrantStock Option (Right to Buy) · Derivative 110,000 $0.00 Strike: $4.12 $0.00
Disclosure

SEC source: 0000899243-22-008370 · doc4.xml · derivative · entry 1

Barone Francesca · CIK 0001909680 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,000

Underlying: Common Stock · 110,000 shares

Expires 2032-02-28

F1 · derivative.exercise_date: This option is subject to time-based and performance-based vesting. The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following the Grant Date, subject to the Reporting Person's continued service on each such vesting date; provided, however, that one-third of the shares underlying this option shall only become exercisable if the average market price of the Issuer's common stock equals or exceeds $13.50 for any ten consecutive trading days prior to or as of December 31, 2022, and an additional one-third of the shares underlying this option shall only become exercisable if the average market price of the Issuer's common stock equals or exceeds $20.00 for any ten consecutive trading days prior to or as of December 31, 2022.

Read SEC document
February 28, 2022 Filed Mar 1, 2022 18:40 UTC
Canepa John JChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 110,000 $0.00 Strike: $4.12 $0.00
Disclosure

SEC source: 0000899243-22-008377 · doc4.xml · derivative · entry 1

Canepa John J · CIK 0001589238 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,000

Underlying: Common Stock · 110,000 shares

Expires 2032-02-28

F1 · derivative.exercise_date: This option is subject to time-based and performance-based vesting. The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following the Grant Date, subject to the Reporting Person's continued service on each such vesting date; provided, however, that one-third of the shares underlying this option shall only become exercisable if the average market price of the Issuer's common stock equals or exceeds $13.50 for any ten consecutive trading days prior to or as of December 31, 2022, and an additional one-third of the shares underlying this option shall only become exercisable if the average market price of the Issuer's common stock equals or exceeds $20.00 for any ten consecutive trading days prior to or as of December 31, 2022.

Read SEC document
February 28, 2022 Filed Mar 1, 2022 23:35 UTC
Tak Paul PeterDirector · Chief Executive Officer
GrantStock Option (Right to Buy) · Derivative 330,000 $0.00 Strike: $4.12 $0.00
Disclosure

SEC source: 0000899243-22-008373 · doc4.xml · derivative · entry 1

Tak Paul Peter · CIK 0001873905 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 330,000

Underlying: Common Stock · 330,000 shares

Expires 2032-02-28

F1 · derivative.exercise_date: This option is subject to time-based and performance-based vesting. The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following the Grant Date, subject to the Reporting Person's continued service on each such vesting date; provided, however, that one-third of the shares underlying this option shall only become exercisable if the average market price of the Issuer's common stock equals or exceeds $13.50 for any ten consecutive trading days prior to or as of December 31, 2022, and an additional one-third of the shares underlying this option shall only become exercisable if the average market price of the Issuer's common stock equals or exceeds $20.00 for any ten consecutive trading days prior to or as of December 31, 2022.

Read SEC document
February 03, 2022 Filed Feb 7, 2022 22:40 UTC
Barone FrancescaChief Scientific Officer
GrantStock Option (Right to Buy) · Derivative 40,000 $0.00 Strike: $4.06 $0.00
Disclosure

SEC source: 0000899243-22-005079 · doc4.xml · derivative · entry 1

Barone Francesca · CIK 0001909680 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2032-02-03

F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in forty-eight equal monthly installments over four years following the Grant Date, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
July 29, 2021 Filed Jul 30, 2021 01:02 UTC PurchaseCommon Stock 20,000 $7.30 $145,944.00
Disclosure

SEC source: 0000899243-21-030774 · doc4.xml · nonDerivative · entry 2

Manning Paul B · CIK 0001494695 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,000

F3 · price: The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $6.855 to $7.80. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.

F2 · ownership.direct: Shares held jointly with spouse.

Read SEC document
July 29, 2021 Filed Aug 3, 2021 00:12 UTC ConversionSeries B Preferred Stock · Derivative 696,851 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-031104 · doc4.xml · derivative · entry 3

Martell Christopher · CIK 0001873465 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By GTAM1 2012 ADV LLC

Disclosed balance after: 0

Underlying: Common Stock · 283,514 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date.

F1 · derivative.exercise_date: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date.

F1 · derivative.expiration_date: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date.

F2 · ownership.nature: Shares held by GTAM1 2012 ADV LLC, for which the Reporting Person serves as manager. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any.

Read SEC document
July 29, 2021 Filed Aug 3, 2021 00:12 UTC PurchaseCommon Stock 125,000 $8.00 $1,000,000.00
Disclosure

SEC source: 0000899243-21-031104 · doc4.xml · nonDerivative · entry 2

Martell Christopher · CIK 0001873465 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By GTAM1 2012 LLC

Disclosed balance after: 125,000

F3 · ownership.nature: Shares held by GTAM1 2012 LLC, which is wholly owned by a trust for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any.

Read SEC document
July 29, 2021 Filed Aug 3, 2021 00:12 UTC ConversionCommon Stock 283,514 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-21-031104 · doc4.xml · nonDerivative · entry 1

Martell Christopher · CIK 0001873465 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By GTAM1 2012 ADV LLC

Disclosed balance after: 283,514

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date.

F2 · ownership.nature: Shares held by GTAM1 2012 ADV LLC, for which the Reporting Person serves as manager. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any.

Read SEC document
July 29, 2021 Filed Aug 2, 2021 20:02 UTC
Caffo NathanChief Business Officer
PurchaseCommon Stock 6,000 $8.00 $48,000.00
Disclosure

SEC source: 0000899243-21-031086 · doc4.xml · nonDerivative · entry 1

Caffo Nathan · CIK 0001816992 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,000

Read SEC document
July 29, 2021 Filed Aug 3, 2021 00:11 UTC
Nguyen DiemDirector
PurchaseCommon Stock 10,000 $8.00 $80,000.00
Disclosure

SEC source: 0000899243-21-031102 · doc4.xml · nonDerivative · entry 1

Nguyen Diem · CIK 0001814338 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Read SEC document
July 29, 2021 Filed Aug 3, 2021 00:08 UTC ConversionSeries B Preferred Stock · Derivative 1,361,069 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-031096 · doc4.xml · derivative · entry 5

Manning Paul B · CIK 0001494695 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By BKB Growth Investments, LLC

Disclosed balance after: 0

Underlying: Common Stock · 553,752 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date.

F1 · derivative.exercise_date: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date.

F1 · derivative.expiration_date: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date.

F3 · ownership.nature: The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the manager of BKB, and has shared voting and investment power with respect to the shares held by BKB. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
July 29, 2021 Filed Aug 3, 2021 00:08 UTC ConversionSeries B Preferred Stock · Derivative 1,669,303 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-031096 · doc4.xml · derivative · entry 4

Manning Paul B · CIK 0001494695 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Paul B. Manning Revocable Trust

Disclosed balance after: 0

Underlying: Common Stock · 679,158 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date.

F1 · derivative.exercise_date: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date.

F1 · derivative.expiration_date: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date.

F2 · ownership.nature: The shares are held by The Paul B. Manning Revocable Trust dated May 10, 2000 (the "Trust"). The Reporting Person is the trustee of the Trust and has sole voting and investment power with respect to the shares held by the Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
July 29, 2021 Filed Aug 3, 2021 00:08 UTC ConversionCommon Stock 553,752 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-21-031096 · doc4.xml · nonDerivative · entry 2

Manning Paul B · CIK 0001494695 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By BKB Growth Investments, LLC

Disclosed balance after: 553,752

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date.

F3 · ownership.nature: The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the manager of BKB, and has shared voting and investment power with respect to the shares held by BKB. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
July 29, 2021 Filed Aug 3, 2021 00:08 UTC ConversionCommon Stock 679,158 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-21-031096 · doc4.xml · nonDerivative · entry 1

Manning Paul B · CIK 0001494695 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Paul B. Manning Revocable Trust

Disclosed balance after: 679,158

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date.

F2 · ownership.nature: The shares are held by The Paul B. Manning Revocable Trust dated May 10, 2000 (the "Trust"). The Reporting Person is the trustee of the Trust and has sole voting and investment power with respect to the shares held by the Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
July 29, 2021 Filed Aug 2, 2021 20:06 UTC
Canepa John JChief Financial Officer
PurchaseCommon Stock 10,125 $8.00 $81,000.00
Disclosure

SEC source: 0000899243-21-031092 · doc4.xml · nonDerivative · entry 1

Canepa John J · CIK 0001589238 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,125

Read SEC document
July 29, 2021 Filed Aug 3, 2021 00:12 UTC
Aguilar-Cordova EstuardoDirector · Chief Scientific Officer
ConversionSeries B Preferred Stock · Derivative 398,519 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-031103 · doc4.xml · derivative · entry 3

Aguilar-Cordova Estuardo · CIK 0001873919 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 162,137 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date.

F1 · derivative.exercise_date: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date.

F1 · derivative.expiration_date: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date.

F2 · ownership.direct: Includes 32,399 shares of common stock held jointly with spouse.

Read SEC document
July 29, 2021 Filed Aug 3, 2021 00:12 UTC
Aguilar-Cordova EstuardoDirector · Chief Scientific Officer
ConversionCommon Stock 162,137 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-21-031103 · doc4.xml · nonDerivative · entry 1

Aguilar-Cordova Estuardo · CIK 0001873919 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,015,923

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date.

F2 · balance_after: Includes 32,399 shares of common stock held jointly with spouse.

F2 · ownership.direct: Includes 32,399 shares of common stock held jointly with spouse.

Read SEC document
July 29, 2021 Filed Aug 3, 2021 00:09 UTC
Tak Paul PeterDirector · Chief Executive Officer
PurchaseCommon Stock 25,000 $8.00 $200,000.00
Disclosure

SEC source: 0000899243-21-031097 · doc4.xml · nonDerivative · entry 1

Tak Paul Peter · CIK 0001873905 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Read SEC document
July 29, 2021 Filed Aug 3, 2021 00:04 UTC
Aguilar Laura K.Chief Medical Officer
ConversionSeries B Preferred Stock · Derivative 137,881 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-031088 · doc4.xml · derivative · entry 3

Aguilar Laura K. · CIK 0001873915 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 56,096 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date.

F1 · derivative.exercise_date: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date.

F1 · derivative.expiration_date: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date.

F2 · ownership.direct: Includes 32,399 shares of common stock held jointly with spouse.

Read SEC document
July 29, 2021 Filed Aug 3, 2021 00:04 UTC
Aguilar Laura K.Chief Medical Officer
ConversionCommon Stock 56,096 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-21-031088 · doc4.xml · nonDerivative · entry 1

Aguilar Laura K. · CIK 0001873915 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 931,039

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date.

F2 · balance_after: Includes 32,399 shares of common stock held jointly with spouse.

F2 · ownership.direct: Includes 32,399 shares of common stock held jointly with spouse.

Read SEC document
July 29, 2021 Filed Aug 4, 2021 20:41 UTC Amendment
Manning Paul BDirector · 10% owner
ConversionSeries B Preferred Stock · Derivative 1,361,069 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-031614 · doc4a.xml · derivative · entry 5

Manning Paul B · CIK 0001494695 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By BKB Growth Investments, LLC

Disclosed balance after: 0

Underlying: Common Stock · 553,752 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date.

F1 · derivative.exercise_date: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date.

F1 · derivative.expiration_date: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date.

F3 · ownership.nature: The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the manager of BKB, and has shared voting and investment power with respect to the shares held by BKB. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
July 29, 2021 Filed Aug 4, 2021 20:41 UTC Amendment
Manning Paul BDirector · 10% owner
ConversionSeries B Preferred Stock · Derivative 1,669,303 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-031614 · doc4a.xml · derivative · entry 4

Manning Paul B · CIK 0001494695 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Paul B. Manning Revocable Trust

Disclosed balance after: 0

Underlying: Common Stock · 679,158 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date.

F1 · derivative.exercise_date: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date.

F1 · derivative.expiration_date: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date.

F2 · ownership.nature: The shares are held by The Paul B. Manning Revocable Trust dated May 10, 2000 (the "Trust"). The Reporting Person is the trustee of the Trust and has sole voting and investment power with respect to the shares held by the Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
July 29, 2021 Filed Aug 4, 2021 20:41 UTC Amendment
Manning Paul BDirector · 10% owner
PurchaseCommon Stock 1,625,000 $8.00 $13,000,000.00
Disclosure

SEC source: 0000899243-21-031614 · doc4a.xml · nonDerivative · entry 3

Manning Paul B · CIK 0001494695 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,681,000

F4 · ownership.direct: Includes shares held jointly with spouse.

Read SEC document
July 29, 2021 Filed Aug 4, 2021 20:41 UTC Amendment
Manning Paul BDirector · 10% owner
ConversionCommon Stock 553,752 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-21-031614 · doc4a.xml · nonDerivative · entry 2

Manning Paul B · CIK 0001494695 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By BKB Growth Investments, LLC

Disclosed balance after: 553,752

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date.

F3 · ownership.nature: The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the manager of BKB, and has shared voting and investment power with respect to the shares held by BKB. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
July 29, 2021 Filed Aug 4, 2021 20:41 UTC Amendment
Manning Paul BDirector · 10% owner
ConversionCommon Stock 679,158 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-21-031614 · doc4a.xml · nonDerivative · entry 1

Manning Paul B · CIK 0001494695 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Paul B. Manning Revocable Trust

Disclosed balance after: 679,158

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date.

F2 · ownership.nature: The shares are held by The Paul B. Manning Revocable Trust dated May 10, 2000 (the "Trust"). The Reporting Person is the trustee of the Trust and has sole voting and investment power with respect to the shares held by the Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
July 27, 2021 Filed Jul 30, 2021 01:02 UTC PurchaseCommon Stock 36,000 $7.36 $264,834.00
Disclosure

SEC source: 0000899243-21-030774 · doc4.xml · nonDerivative · entry 1

Manning Paul B · CIK 0001494695 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,000

F1 · price: The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $7.31 to $7.40. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.

F2 · ownership.direct: Shares held jointly with spouse.

Read SEC document
July 26, 2021 Filed Feb 14, 2022 21:43 UTC
Nguyen DiemDirector
GrantStock Option (Right to Buy) · Derivative 28,840 $0.00 Strike: $8.00 $0.00
Disclosure

SEC source: 0000899243-22-006188 · doc5.xml · derivative · entry 1

Nguyen Diem · CIK 0001814338 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,840

Underlying: Common Stock · 28,840 shares

Expires 2031-07-26

F1 · derivative.exercise_date: This option shall vest and become exercisable in thirty-six equal monthly installments following July 26, 2021, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
July 26, 2021 Filed Feb 15, 2022 01:31 UTC Amendment
Nguyen DiemDirector
GrantStock Option (Right to Buy) · Derivative 28,480 $0.00 Strike: $8.00 $0.00
Disclosure

SEC source: 0000899243-22-006325 · doc5a.xml · derivative · entry 1

Nguyen Diem · CIK 0001814338 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,480

Underlying: Common Stock · 28,480 shares

Expires 2031-07-26

F1 · derivative.exercise_date: This option shall vest and become exercisable in thirty-six equal monthly installments following July 26, 2021, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.